Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Inju Cho
Comparison of Efficacy of Pembrolizumab Between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas
Cancer Research and Treatment
Cancer Research
Oncology
Related publications
Safety and Efficacy of Atezolizumab, Obinutuzumab and Venetoclax Combination for Relapsed/Refractory Non-Hodgkin Lymphomas: Results From the Safety-Run of a Lysa Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Investigating Safety and Preliminary Efficacy of Afm13 Plus Pembrolizumab in Patients With Relapsed/Refractory Hodgkin Lymphoma After Brentuximab Vedotin Failure
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Sinonasal Lymphomas in Indonesia: Immunophenotype and Epstein-Barr Virus Association
Medical Journal of Indonesia
Medicine
Lymphoma Associated With Epstein-Barr Virus-Positive Pyothorax
Internal Medicine
Internal Medicine
Medicine
Dominant-Negative Inhibitors of EBNA-1 of Epstein-Barr Virus.
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
HIV Positivity May Not Have a Negative Impact on Survival in Epstein‑Barr Virus‑positive Hodgkin Lymphoma: A Japanese Nationwide Retrospective Survey
Oncology Letters
Cancer Research
Oncology
Clinical Characteristics and Treatment Results of Pediatric Relapsed/Refractory Non-Hodgkin’s Lymphomas
Oncogematologiya
Oncology
Hematology
PI3Kδ Inhibition Augments the Efficacy of Rapamycin in Suppressing Proliferation of Epstein−Barr Virus (EBV)+ B Cell Lymphomas
American Journal of Transplantation
Transplantation
Allergy
Immunology
Pharmacology
Zidovudine-Based Lytic-Inducing Chemotherapy for Epstein–Barr Virus-Related Lymphomas
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
